BJU International, 1464-4096

Journal

More filtering options
  1. 2019
  2. Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

    Fredrik Liedberg, Oskar Hagberg, Aljabery, F., Gårdmark, T., Hosseini, A., Jahnson, S., Georg Jancke, Jerlström, T., Malmström, P. U., Sherif, A., Ströck, V., Häggström, C. & Holmberg, L., 2019 Apr 19, In : BJU International.

    Research output: Contribution to journalArticle

  3. Oxidative stress and lower urinary tract symptoms: cause or consequence?

    Karl Erik Andersson, 2019, In : BJU International. 123, 5, p. 749-750 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  4. 2018
  5. The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

    Bruinsma, S. M., Zhang, L., Roobol, M. J., Bangma, C. H., Steyerberg, E. W., Nieboer, D., Van Hemelrijck, M., Anders Bjartell & Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium, 2018 May, In : BJU International. 121, 5, p. 737-744

    Research output: Contribution to journalArticle

  6. Familial risks in urolithiasis in the population of Sweden

    Kari Hemminki, Hemminki, O., Asta Försti, Kristina Sundquist, Jan Sundquist & Xinjun Li, 2018 Mar 1, In : BJU International. 121, 3, p. 479-485 7 p.

    Research output: Contribution to journalArticle

  7. 2017
  8. Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch

    Fredrik Liedberg, Gudjonsson, S., Xu, A., Pär Ola Bendahl, Davidsson, T. & Wiking Månsson, 2017, In : BJU International. 120, 4, p. 530-536

    Research output: Contribution to journalArticle

  9. Sentinel node biopsy for prostate cancer: Report from a consensus panel meeting

    Van der Poel, H. G., Wit, E. M. K., Acar, C., van den Berg, N. S., van Leeuwen, F. W. B., Valdes Olmos, R. A., Winter, A., Wawroschek, F., Fredrik Liedberg, MacLennan, S. & Lam, T., 2017, In : BJU International. 120, 2, p. 204-211

    Research output: Contribution to journalArticle

  10. Socioeconomic factors and penile cancer risk and mortality; a population-based study

    Torbrand, C., Wigertz, A., Drevin, L., Folkvaljon, Y., Lambe, M., Håkansson, U. & Kirrander, P., 2017, In : BJU International. 119, 2, p. 254-260

    Research output: Contribution to journalArticle

  11. 2016
  12. Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.

    Carlsson, S., Jäderling, F., Wallerstedt, A., Nyberg, T., Stranne, J., Thorsteinsdottir, T., Carlsson, S. V., Anders Bjartell, Hugosson, J., Haglind, E. & Steineck, G., 2016 Aug, In : BJU International. 118, 2, p. 205-12

    Research output: Contribution to journalArticle

  13. Interpretation of conventional survival analysis and competing risk analysis: An example of hypertension and prostate cancer

    Häggström, C., Stattin, P., Tanja Stocks, Garmo, H., Holmberg, L. & Van Hemelrijck, M., 2016 Mar 31, In : BJU International. 118, 6, p. 850–852

    Research output: Contribution to journalArticle

  14. The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012.

    Danneman, D., Drevin, L., Delahunt, B., Samaratunga, H., Robinson, D., Ola Bratt, Loeb, S., Stattin, P. & Egevad, L., 2016, In : BJU International.

    Research output: Contribution to journalArticle

  15. 2015
  16. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts

    Ahmed, K., Khan, R., Mottrie, A., Lovegrove, C., Abaza, R., Ahlawat, R., Ahlering, T., Ahlgren, G., Artibani, W., Barret, E., Cathelineau, X., Challacombe, B., Coloby, P., Khan, M. S., Hubert, J., Michel, M. S., Montorsi, F., Murphy, D., Palou, J., Patel, V. & 19 othersPiechaud, P-T., Van Poppel, H., Rischmann, P., Sanchez-Salas, R., Siemer, S., Stoeckle, M., Stolzenburg, J-U., Terrier, J-E., Thueroff, J. W., Vaessen, C., Van der Poel, H. G., Van Cleynenbreugel, B., Volpe, A., Wagner, C., Wiklund, P., Wilson, T., Wirth, M., Witt, J. & Dasgupta, P., 2015, In : BJU International. 116, 1, p. 93-101

    Research output: Contribution to journalArticle

  17. Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.

    Ola Bratt, Folkvaljon, Y., Loeb, S., Klotz, L., Egevad, L. & Stattin, P., 2015, In : BJU International. 116, 2, p. 213-219

    Research output: Contribution to journalArticle

  18. URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats.

    Aizawa, N., Gandaglia, G., Petter Hedlund, Fujimura, T., Fukuhara, H., Montorsi, F., Homma, Y. & Igawa, Y., 2015, In : BJU International.

    Research output: Contribution to journalArticle

  19. 2014
  20. Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?

    Wolff, J. M., Abrahamsson, P-A., Irani, J. & da Silva, F. C., 2014, In : BJU International. 114, 4, p. 476-483

    Research output: Contribution to journalReview article

  21. 2013
  22. Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

    Carlsson, S. V., Peltola, M. T., Sjoberg, D., Schroder, F. H., Hugosson, J., Pettersson, K., Scardino, P. T., Vickers, A. J., Hans Lilja & Roobol, M. J., 2013, In : BJU International. 112, 5, p. 602-609

    Research output: Contribution to journalArticle

  23. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.

    Ladjevardi, S., Berglund, A., Varenhorst, E., Ola Bratt, Widmark, A. & Sandblom, G., 2013, In : BJU International. 111, 3, p. 381-388

    Research output: Contribution to journalArticle

  24. 2012
  25. Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. G. & Ola Bratt, 2012, In : BJU International. 110, 10, p. 1501-1506

    Research output: Contribution to journalArticle

  26. Testosterone in prostate cancer: the Bethesda consensus.

    Djavan, B., Eastham, J., Gomella, L., Tombal, B., Taneja, S., Dianat, S. S., Kazzazi, A., Shore, N., Abrahamsson, P-A., Cheetham, P., Moul, J., Lepor, H. & Crawford, E. D., 2012, In : BJU International. 110, 3, p. 344-352

    Research output: Contribution to journalArticle

  27. 2011
  28. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.

    Hoogland, A. M., Dahlman, A. K., Vissers, K. J., Wolters, T., Schröder, F., Roobol, M., Anders Bjartell & van Leenders, G. J. L. H., 2011, In : BJU International. 108, 8, p. 1356-1362

    Research output: Contribution to journalArticle

  29. The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).

    Gudjonsson, S., Bläckberg, M., Chebil, G., Jahnson, S., Olsson, H., Pär-Ola Bendahl, Wiking Månsson & Fredrik Liedberg, 2011, In : BJU International.

    Research output: Contribution to journalArticle

  30. 2010
  31. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study

    Mattiasson, A., Masala, A., Morton, R. & Bolodeoku, J., 2010, In : BJU International. 105, 8, p. 1126-1135

    Research output: Contribution to journalArticle

  32. 2009
  33. Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

    Schroeder, F. H., Bangma, C. H., Wolff, J. M., Alcaraz, A., Montorsi, F., Mongiat-Artus, P., Abrahamsson, P-A., McNicholas, T. A., Castro, R. S. & Nandy, I. M., 2009, In : BJU International. 103, 5, p. 590-596

    Research output: Contribution to journalArticle

  34. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

    Jhavar, S., Brewer, D., Edwards, S., Kote-Jarai, Z., Attard, G., Clark, J., Flohr, P., Christmas, T., Thompson, A., Parker, M., Shepherd, C., Stenman, U-H., Marchbank, T., Playford, R. J., Woodhouse, C., Ogden, C., Fisher, C., Kovacs, G., Corbishley, C., Jameson, C. & 5 othersNorman, A., De-Bono, J., Anders Bjartell, Eeles, R. & Cooper, C. S., 2009, In : BJU International. 103, 9, p. 1256-1269

    Research output: Contribution to journalArticle

  35. Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.

    Bellmunt, J., Flodgren, P., Roigas, J. & Oudard, S., 2009, In : BJU International. 104, p. 10-18

    Research output: Contribution to journalArticle

  36. Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

    Saad, F., Abrahamsson, P-A. & Miller, K., 2009, In : BJU International. 104, 11, p. 1573-1579

    Research output: Contribution to journalReview article

  37. THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: 'DO NOT THROW THE BABY OUT WITH THE BATH WATER'

    Challacombe, B. J., Murphy, D., Hans Lilja, Vickers, A. J. & Costello, A. J., 2009, In : BJU International. 104, p. 1553-1554

    Research output: Contribution to journalArticle

  38. The developing role of hormonal therapy in the treatment of prostate cancer.

    Abrahamsson, P-A., 2009, In : BJU International. 103 Suppl 2, p. 41275

    Research output: Contribution to journalArticle

  39. Treatment of prostate cancer with hormonal therapy in Europe

    Miller, K., Anderson, J. & Abrahamsson, P-A., 2009, In : BJU International. 103, p. 41311

    Research output: Contribution to journalArticle

  40. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.

    Werkström, V., Petter Hedlund, Lee, T. & Karl-Erik Andersson, 2009, In : BJU International. 104, p. 1740-1745

    Research output: Contribution to journalArticle

  41. 2008
  42. Incontinent urinary diversion.

    Gudjonsson, S., Davidsson, T. & Wiking Månsson, 2008, In : BJU International. 102, 9 Pt B, p. 1320-1325

    Research output: Contribution to journalArticle

  43. Management of advanced prostate cancer: can we improve on androgen deprivation therapy?

    Anderson, J., Abrahamsson, P-A., Crawford, D., Miller, K. & Tombal, B., 2008, In : BJU International. 101, p. 1497-1501

    Research output: Contribution to journalArticle

  44. Non-genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue

    Waldkirch, E., Ucker, S., Schultheiss, D., Geismar, U., Bruns, C., Scheller, F., Jonas, U., Becker, A. J., Stief, C. G. & Petter Hedlund, 2008, In : BJU International. 101, 1, p. 71-74

    Research output: Contribution to journalArticle

  45. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.

    Ney, P., Pandita, R. K., Newgreen, D. T., Breidenbach, A., Stöhr, T. & Karl-Erik Andersson, 2008, In : BJU International. 101, p. 1036-1042

    Research output: Contribution to journalArticle

  46. 2007
  47. Active surveillance vs radical prostatectomy.

    Abrahamsson, P-A., 2007, In : BJU International. 100, s 2, p. 26-28

    Research output: Contribution to journalArticle

  48. Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1 alpha

    Bivalacqua, T. J., Kendirci, M., Champion, H. C., Hellstrom, W. J. G., Karl-Erik Andersson & Petter Hedlund, 2007, In : BJU International. 99, 6, p. 1488-1494

    Research output: Contribution to journalArticle

  49. What should a urologist know about hereditary predisposition to prostate cancer?

    Ola Bratt, 2007, In : BJU International. 99, 4, p. 743-747

    Research output: Contribution to journalReview article

  50. 2006
  51. Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

    Jiborn, T., Magnus Abrahamson, Gadaleanu, V., Åke Lundwall & Anders Bjartell, 2006, In : BJU International. 98, 1, p. 189-196

    Research output: Contribution to journalArticle

  52. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis

    Vande Walle, JGJ., Bogaert, GA., Mattsson, S., Schurmans, T., Hoebeke, P., Deboe, V. & Norgaard, J. P., 2006, In : BJU International. 97, 3, p. 603-609

    Research output: Contribution to journalArticle

  53. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

    Finney, S. M., Karl-Erik Andersson, Gillespie, J. I. & Stewart, L. H., 2006, In : BJU International. 98, 3, p. 503-507

    Research output: Contribution to journalArticle

  54. Caspase-3-dependent apoptosis in Escherichia coli-infected urothelium: involvement of inducible nitric oxide synthase.

    Andersson, M., Poljakovic, M. & Persson, K., 2006, In : BJU International. 98, 1, p. 160-165

    Research output: Contribution to journalArticle

  55. Effects of a vitamin D analogue in a rat model of bladder outlet obstruction.

    Schroder, A., Colli, E., Maggi, M. & Karl-Erik Andersson, 2006, In : BJU International. 98, 3, p. 637-642

    Research output: Contribution to journalArticle

  56. Location of interstitial cells and neurotransmitters in the mouse bladder

    Lagou, M., De Vente, J., Kirkwood, TB., Petter Hedlund, Karl-Erik Andersson, Gillespie, JI. & Drake, MJ., 2006, In : BJU International. 97, 6, p. 1332-1337

    Research output: Contribution to journalArticle

  57. Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis

    Benigni, F., Baroni, E., Zecevic, M., Zvara, P., Streng, T., Petter Hedlund, Colli, E., D'Ambrosio, D. & Karl-Erik Andersson, 2006, In : BJU International. 97, 3, p. 617-624

    Research output: Contribution to journalArticle

  58. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation.

    Karl-Erik Andersson, Mulhall, J. P. & Wyllie, M. G., 2006, In : BJU International. 97, 2, p. 311-315

    Research output: Contribution to journalArticle

  59. Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat.

    Streng, T., Petter Hedlund, Talo, A., Karl-Erik Andersson & Gillespie, J. I., 2006, In : BJU International. 97, 5, p. 1094-1101

    Research output: Contribution to journalArticle

Previous 1 2 Next